Not Yet RecruitingPhase 3

of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve

Egypt200 participantsStarted 2024-06-30

Plain-language summary

To evaluate the role of Myo-inositol, melatonin and co-enzyme Q10 on ovarian reserve parameters and ICSI outcome in poor ovarian responder

Age range20 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Any endocrine or metabolic disorder such as hyperprolactinemia, diabetes and thyroid dysfunction
✕. Any pelvic pathology such as hydrosalpinx, uterine anomaly.
✕. Any male factor infertility such as Oligo-Astheno-Teratozoospermia (OAT) or azoospermia

pregnancy

Timeframe: 1 month of induction for ICSI trial

NCT IDNCT06405204

SponsorBeni-Suef University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12-30

Sara S Sara Salem, MD